These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8630434)

  • 1. A genetic view on the etiology of the inhibitor complication.
    Giannelli F; Green PM; Naylor JA
    Blood; 1996 Mar; 87(6):2612. PubMed ID: 8630434
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of genetics in inhibitor formation.
    Gill JC
    Thromb Haemost; 1999 Aug; 82(2):500-4. PubMed ID: 10605742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 4. Key issues in inhibitor management in patients with haemophilia.
    Gomez K; Klamroth R; Mahlangu J; Mancuso ME; Mingot ME; Ozelo MC
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s319-29. PubMed ID: 24333092
    [No Abstract]   [Full Text] [Related]  

  • 5. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.
    Chuansumrit A; Sasanakul W; Sirachainan N; Kadegasem P; Wongwerawattanakoon P; Mahaklan L; Nathalang O
    Haemophilia; 2017 Nov; 23(6):e518-e523. PubMed ID: 28891589
    [No Abstract]   [Full Text] [Related]  

  • 7. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.
    Gouw SC; van den Berg HM
    Semin Thromb Hemost; 2009 Nov; 35(8):723-34. PubMed ID: 20169509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
    Astermark J
    Haemophilia; 2006 Jul; 12 Suppl 3():52-60. PubMed ID: 16683997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and genetic factors influencing inhibitor development.
    Oldenburg J; Schröder J; Brackmann HH; Müller-Reible C; Schwaab R; Tuddenham E
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):82-8. PubMed ID: 14872427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching haemophilia products and inhibitor risk: a United States' perspective.
    Nance D; Rodgers GM
    Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular basis of haemophilia A and B.
    Giannelli F; Green PM
    Baillieres Clin Haematol; 1996 Jun; 9(2):211-28. PubMed ID: 8800501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The occurrence of immunological tolerance to inhibitors of factors VIII and IX in hemophilia patients].
    Brakman GG
    Gematol Transfuziol; 1993 Feb; 38(2):18-20. PubMed ID: 8020714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetics of hemophilia A and B in man. Factor VIII and factor IX deficiency.
    Antonarakis SE
    Adv Hum Genet; 1988; 17():27-59. PubMed ID: 3142226
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors - cellular aspects and novel approaches for tolerance.
    Scott DW
    Haemophilia; 2014 May; 20 Suppl 4(0 4):80-6. PubMed ID: 24762281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of hemophilia.
    Lozier JN; High KA
    Hematol Pathol; 1990; 4(1):1-26. PubMed ID: 2111315
    [No Abstract]   [Full Text] [Related]  

  • 17. [DNA analysis in the inhibitor phenotype of the hemophilias].
    Yamamoto K; Takahashi I
    Rinsho Ketsueki; 1993 May; 34(5):578-82. PubMed ID: 8315828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic diagnosis in haemophiliacs (haemophilia A, B, carrier)].
    Mikami S
    Rinsho Byori; 1990 Jun; Suppl 85():102-13. PubMed ID: 1976834
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterozygote frequencies of common polymorphic markers of factor VIII (f8) and factor IX (f9) genes in indigenous Nepali population.
    Kanani P; Poudyal BS; Shetty S; Kapali SM; Ghosh K
    Haemophilia; 2012 Mar; 18(2):e44-5. PubMed ID: 22221849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Structure and function of factor VIII and factor IX gene and molecular DNA diagnosis in hemophilia A and B].
    Herrmann FH; Wehnert M; Wulff K
    Z Arztl Fortbild (Jena); 1988; 82(22):1116-22. PubMed ID: 2907834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.